Dr. Ulahannan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 NE 10th St
Oklahoma City, OK 73104Phone+1 405-271-1632
Summary
- Dr. Susanna Ulahannan is a specialist in Oncology with subspecialties in Gastrointestinal Cancer and Hematologic Oncology, based in Oklahoma City. She completed her residency in Internal Medicine at Sinai Hospital of Baltimore (2008 - 2011) and fellowship in Hematology and Medical Oncology at the National Institutes of Health Clinical Center (2011 - 2014). Since 2017, she serves as an Assistant Clinical Professor at University of Oklahoma College of Medicine. Dr. Ulahannan's extensive experience covers areas including neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and myelodysplasia. Significant contributions to her field are documented in her multiple publications that includes studies in JHEP Reports, Nature Medicine and Journal of Hepatology, among others. She was also recognized with a Merit Award from the Gastrointestinal Cancers Symposium in 2015.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Sinai Hospital of BaltimoreResidency, Internal Medicine, 2008 - 2011
- Univ of Gothenburg- Fac MedClass of 2002
Certifications & Licensure
- OK State Medical License 2014 - 2026
- MD State Medical License 2011 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Merit Award Gastrointestinal Cancers Symposium, 2015
Publications & Presentations
PubMed
- Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide.Vishnu Nagalapuram, Niveditha Popuri, Ryan D Nipp, Susanna V Ulahannan, Kelsey S Lau-Min
JCO Oncology Practice. 2025-03-03 - 1 citationsHepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea
Hepatology. 2025-03-01 - CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid t...J Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y Chung
BJC Reports. 2025-02-27
Journal Articles
- Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?Ulahannan SV, Duffy AG, Hepatic Oncology, 8/19/2016
- Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combinati...Duffy A, Makarova-Rusher OV, Ulahannan SV et al, Internal Journal of Cancer, 1/19/2016
- Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesUlahannan SV, Rahma OE, Duffy AG, et al, Hepatic Oncology, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Epidemiology and Survival in Patients with Extragastric Signet Ring CarcinomaC Kim, SV Ulahannan, J Strauss et al, American association for Cancer Research (AACR), New Orleans, LA, 1/1/2016
- Pretreatment CEA levels predict survival in patients with rectal adenocarcinomaOV Makarova-Rusher, J Strauss, SV Ulahannan et al, American association for Cancer Research (AACR), New Orleans, LA, 1/1/2016
- Tremelimumab: A monoclonal antibody against CTLA-4-In combination with subtotal ablation (trans catheter arterial chemoembolization (TACE), radiofrequency ablation (RF...Austin G. Duffy, Oxana V. Makarova-Rusher, Susanna Ulahannan et al, J Clin Oncol; ASCO Annual Meeting, Chicago, IL, 1/1/2016
- Join now to see all
Press Mentions
- As More People with Cancer Use Medical Cannabis, Oncologists Face Questions They Struggle to AnswerOctober 16th, 2024
- Research at Stephenson Cancer Center Helps Rescue Oklahoma Man from CancerDecember 10th, 2021
- Oklahoma Man Discusses Surviving Colorectal Cancer After Being Told He Had Weeks to LiveApril 14th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: